Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula A Matulonis

Showing results (141-150 of 215) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancerUrsula A Matulonis, Julie Lee, Brian Lasonde, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 7, 2016
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomasLauren L Ritterhouse, Jonathan A Nowak, Kyle C Strickland, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2008
Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 casesMariana C Castells, Nichole M Tennant, David E Sloane, et al.
JAMA Oncology|July 22, 2016
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian CancerKatharine M Esselen, Angel M Cronin, Kristin Bixel, et al.
Cancer|September 17, 2013
Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervixAlexi A Wright, Brooke E Howitt, Andrea P Myers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectivesAndrew D Zelenetz, Islah Ahmed, Edward Louis Braud, et al.
Gynecologic Oncology|December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology studyUrsula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.
International Journal of Cancer|November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancerAndrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerAlexi A Wright, Angel Cronin, Dana E Milne, et al.
The Lancet. Oncology|July 21, 2018
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trialAmit M Oza, Ursula A Matulonis, Susanne Malander, et al.
Pageof 22

Showing results (141-150 of 215) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancerUrsula A Matulonis, Julie Lee, Brian Lasonde, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 7, 2016
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomasLauren L Ritterhouse, Jonathan A Nowak, Kyle C Strickland, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2008
Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 casesMariana C Castells, Nichole M Tennant, David E Sloane, et al.
JAMA Oncology|July 22, 2016
Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian CancerKatharine M Esselen, Angel M Cronin, Kristin Bixel, et al.
Cancer|September 17, 2013
Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervixAlexi A Wright, Brooke E Howitt, Andrea P Myers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2011
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectivesAndrew D Zelenetz, Islah Ahmed, Edward Louis Braud, et al.
Gynecologic Oncology|December 14, 2021
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology studyUrsula A Matulonis, Helen Q Huang, Virginia L Filiaci, et al.
International Journal of Cancer|November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancerAndrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian CancerAlexi A Wright, Angel Cronin, Dana E Milne, et al.
The Lancet. Oncology|July 21, 2018
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trialAmit M Oza, Ursula A Matulonis, Susanne Malander, et al.
Pageof 22